Defects in glanzmann thrombasthenia and LAD-III (LAD-1/v) syndrome: The role of integrin β1 and β3 in platelet adhesion to collagen

Blood

Volumn 119, Issue 2, 2012, Pages 583-586

  Van De Vijver, Edith ^a   De Cuyper, Iris M ^a   Gerrits, Anja J ^a   Verhoeven, Arthur J ^a   Seeger, Karl ^b   Gutiérrez, Laura ^a   Van Den Berg, Timo K ^a   Kuijpers, Taco W ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; BETA3 INTEGRIN; COLLAGEN; FIBRINOGEN RECEPTOR; RISTOCETIN;

ARTICLE; ASSAY; BLEEDING TENDENCY; CLINICAL ASSESSMENT; FLOW CYTOMETRY; GENETIC VARIABILITY; GLANZMANN DISEASE; LEUKOCYTE ADHESION DEFICIENCY; LEUKOCYTE ADHESION DEFICIENCY III SYNDROME; LIGHT TRANSMISSION AGGREGOMETRY; PHENOTYPE; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 84855857711     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-337188     Document Type: Article

References (25)

1. Lecut C, Schoolmeester A, Kuijpers MJ, et al. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation. Arterioscler Thromb Vasc Biol. 2004;24(9):1727-1733. (Pubitemid 39180902)
2. Nieswandt B, Brakebusch C, Bergmeier W, et al. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J. 2001;20(9):2120-2130. (Pubitemid 32410582)
3. Pugh N, Simpson AM, Smethurst PA, et al. Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood. 2010; 115(24):5069-5079.
4. Saelman EU, Nieuwenhuis HK, Hese KM, et al. Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood. 1994;83(5):1244-1250. (Pubitemid 24062847)
5. Sarratt KL, Chen H, Zutter MM, et al. GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood. 2005;106(4):1268-1277. (Pubitemid 41129590)
6. Siljander PR, Munnix IC, Smethurst PA, et al. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood. 2004;103(4):1333-1341. (Pubitemid 38168645)
7. Van de Walle GR, Schoolmeester A, Iserbyt BF, et al. Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets. Blood. 2007;109(2): 595-602. (Pubitemid 46105957)
8. Nuyttens BP, Thijs T, Deckmyn H, Broos K. Platelet adhesion to collagen. Thromb Res. 2011; 127(suppl 2):S26-S29.
9. Du X, Ginsberg MH. Integrin alpha IIb beta 3 and platelet function. Thromb Haemost. 1997;78(1): 96-100. (Pubitemid 27289223)
10. Giannini S, Mezzasoma AM, Guglielmini G, et al. A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometry. Cytometry B Clin Cytom. 2008;74(3):194-199. (Pubitemid 351656300)
11. Kuijpers TW, Van Lier RA, Hamann D, et al. Leukocyte adhesion deficiency type 1 (LAD-1)/variant: a novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest. 1997;100(7):1725-1733. (Pubitemid 27431328)
12. Kuijpers TW, van Bruggen R, Kamerbeek N, et al. Natural history and early diagnosis of LAD-1/variant syndrome. Blood. 2007;109(8):3529-3537. (Pubitemid 46572546)
13. Kuijpers TW, van de Vijver E, Weterman MA, et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood. 2009;113(19):4740-4746.
14. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood. 1990;75(7):1383-1395. (Pubitemid 20114873)
15. Malinin NL, Plow EF, Byzova TV. Kindlins in FERM adhesion. Blood. 2010;115(20):4011-4017.
16. Malinin NL, Zhang L, Choi J, et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med. 2009;15(3): 313-318.
17. Svensson L, Howarth K, McDowall A, et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med. 2009;15(3):306-312.
18. Moser M, Nieswandt B, Ussar S, Pozgajova M, Fassler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med. 2008; 14(3):325-330. (Pubitemid 351347914)
19. Jurk K, Schulz AS, Kehrel BE, et al. Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3. Thromb Haemost. 2010;103(5):1053-1064.
20. Campanero MR, Arroyo AG, Pulido R, et al. Functional role of alpha 2/beta 1 and alpha 4/beta 1 integrins in leukocyte intercellular adhesion induced through the common beta 1 subunit. Eur J Immunol. 1992;22(12):3111-3119.
21. Lecut C, Feeney LA, Kingsbury G, et al. Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments. J Thromb Haemost. 2003;1(12):2653-2662.
22. Munnix IC, Gilio K, Siljander PR, et al. Collagen-mimetic peptides mediate flow-dependent thrombus formation by high- or low-affinity binding of integrin alpha2beta1 and glycoprotein VI. J Thromb Haemost. 2008;6(12):2132- 2142.
23. Picker SM. In-vitro assessment of platelet function. Transfus Apher Sci. 2011;44(3):305-319.
24. Tsuji S, Sugimoto M, Miyata S, et al. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct sheardependent roles of platelet receptors and adhesive proteins under flow. Blood. 1999;94(3): 968-975. (Pubitemid 29361828)
25. McGregor L, Hanss M, Sayegh A, et al. Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa. Thromb Haemost. 1989; 62(3):962-967. (Pubitemid 20005011)